MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,801.77
-0.22%
NASDAQ 100
$31,160.08
-0.21%
DOW JONES
$51,180.00
-0.66%
NASDAQ Composite
$27,538.69
-0.22%
RUSSELL 2000
$2,777.00
-1.29%
CBOE VIX
$15.08
+0.47%

Sector Heatmap

Technology-0.30%
Financials-0.48%
Healthcare+1.03%
Consumer Cycl-0.32%
Consumer Staples-0.12%
Energy-0.58%
Industrials-2.18%
Materials-1.51%
Real Estate-1.29%
Utilities-0.02%
Comm Services-0.35%

ORMP — Oramed Pharmaceuticals Inc.

Nasdaq

Oramed Pharmaceuticals Inc.

CompareBack to Screener
$4.37
-0.01(-0.23%)
O
4.43
H
4.45
L
4.35
V
84.72K
⏱️ End-of-day dataAs of Oct 7, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

Chart

About ORMP

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.

IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateApr 19, 2004
Employees13
Stock ExchangeNasdaq
Ticker SymbolORMP
Websitehttps://www.oramed.com

Key Financial Statistics

Market Cap$186.77M
P/E RatioN/A
Dividend Yield5.72% (Irregular)
EPSN/A
BetaN/A
52-Week Range$2.09 - $5.47
52-Week Avg Volume215.6K
VWAP$4.39
Transactions1,248
Total Recorded Bars4,891 days